Literature DB >> 9639806

Lipids, lipoproteins and apolipoproteins abnormalities in patients undergoing dialysis.

X Yang1, H Wang, Z Zhu, A Deng.   

Abstract

Twenty hemodialysis (HD) patients and 20 patients on continuous ambulatory peritoneal dialysis (CAPD) were investigated for lipids, lipoproteins and apolipoproteins abnormalities. HD patients had elevated serum triglyceride, decreased high-density lipoprotein cholesterol (HDL-C) and apolipoprotein A-I (Apo A-I), while CAPD patients had elevated total cholesterol, triglyceride, low-density lipoprotein cholesterol (LDL-C), Apolipoprotein B (Apo B), Apo B/Apo A-I ratio, and decreased HDL-C, Apo A-I. Because of the molecular sieving effects of peritoneum, CAPD have a negative effect on these abnormalities. CAPD patients might be at greater risk of developing coronary artery disease than HD patients who are also at increased risk as compared with normals.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9639806     DOI: 10.1007/bf02888251

Source DB:  PubMed          Journal:  J Tongji Med Univ        ISSN: 0257-716X


  9 in total

Review 1.  Lipid abnormalities in renal disease.

Authors:  G Appel
Journal:  Kidney Int       Date:  1991-01       Impact factor: 10.612

2.  Decreased clearance of low-density lipoprotein in uremic patients under dialysis treatment.

Authors:  S Hörkkö; K Huttunen; Y A Kesäniemi
Journal:  Kidney Int       Date:  1995-06       Impact factor: 10.612

3.  Low prekallikrein and high angiotensin-converting enzyme activity in patients with chronic renal failure on haemodialysis.

Authors:  T Jankova; P Tchankova; D Nenov
Journal:  Nephrol Dial Transplant       Date:  1991       Impact factor: 5.992

4.  Lipid and apolipoprotein profiles of uremic dyslipoproteinemia--relation to renal function and dialysis.

Authors:  P O Attman; P Alaupovic
Journal:  Nephron       Date:  1991       Impact factor: 2.847

5.  Hyperapobetalipoproteinemia: the major dyslipoproteinemia in patients with chronic renal failure treated with chronic ambulatory peritoneal dialysis.

Authors:  A Sniderman; K Cianflone; P O Kwiterovich; T Hutchinson; P Barre; S Prichard
Journal:  Atherosclerosis       Date:  1987-06       Impact factor: 5.162

6.  Catabolism of low-density lipoprotein is altered in experimental chronic renal failure.

Authors:  R J Shapiro
Journal:  Metabolism       Date:  1993-02       Impact factor: 8.694

Review 7.  Current concepts. Continuous ambulatory peritoneal dialysis.

Authors:  K D Nolph; A S Lindblad; J W Novak
Journal:  N Engl J Med       Date:  1988-06-16       Impact factor: 91.245

Review 8.  Morbidity and mortality of CAPD and hemodialysis.

Authors:  R Maiorca; G C Cancarini; G Brunori; C Camerini; L Manili
Journal:  Kidney Int Suppl       Date:  1993-02       Impact factor: 10.545

9.  Atherosclerosis in uremia: a longitudinal study.

Authors:  V Bonomini; C Feletti; M P Scolari; S Stefoni; A Vangelista
Journal:  Am J Clin Nutr       Date:  1980-07       Impact factor: 7.045

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.